Diamedica Therapeutics's total assets for Q3 2024 were $52.52M, a decrease of -7.51% from the previous quarter. DMAC total liabilities were $4.56M for the fiscal quarter, a 35.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.